Natalizumab company
「Natalizumab company」熱門搜尋資訊
「Natalizumab company」文章包含有：「Applicationsforproposedfirst-of」、「BiogenIdecCompletesPurchaseofFullRightsand...」、「ContactUs」、「Natalizumab」、「Natalizumab:Uses」、「SandozreceivesFDAapprovalforTyruko®(natalizumab...」、「Tyruko®(natalizumab)」、「Tysabri(natalizumab)FDAApprovalHistory」、「TYSABRI®(natalizumab)HCP」、「TYSABRI®(natalizumab)」
查看更多
Applications for proposed first-of
https://www.novartis.com
The US Food and Drug Administration (FDA) has accepted its biologics license application (BLA) for a proposed first-of-a-kind biosimilar natalizumab.
Biogen Idec Completes Purchase of Full Rights and ...
https://investors.biogen.com
Biogen Idec (NASDAQ: BIIB) today announced it has completed its purchase of Elan Corporation's interest in TYSABRI (natalizumab) and has gained full strategic, ...
Contact Us
https://www.tysabri.com
Getting answers to some of your questions about relapsing multiple sclerosis (MS) can be as easy as picking up the phone and calling 1-800-456-2255.
Natalizumab
https://en.wikipedia.org
Natalizumab, sold under the brand name Tysabri among others, is a medication used to treat multiple sclerosis and Crohn's disease.
Natalizumab: Uses
https://go.drugbank.com
Natalizumab is a monoclonal anti-integrin antibody used to treat Crohn's disease or multiple sclerosis. Brand Names. Tysabri. Generic Name: Natalizumab ...
Sandoz receives FDA approval for Tyruko® (natalizumab ...
https://www.novartis.com
Sandoz, a Novartis division, is a global leader in generic pharmaceuticals and biosimilars. Our purpose is to pioneer access for patients by ...
Tyruko® (natalizumab)
https://polpharmabiologics.com
Biosimilar natalizumab was developed by scientists at Polpharma Biologics, and the company retains responsibility for the manufacturing and ...
Tysabri (natalizumab) FDA Approval History
https://www.drugs.com
Company: Biogen Inc. Treatment for: Multiple Sclerosis, Crohn's Disease, Maintenance · Tysabri (natalizumab) is a recombinant humanized IgG4κ monoclonal ...
TYSABRI® (natalizumab) HCP
https://www.tysabrihcp.com
TYSABRI (natalizumab) is indicated as monotherapy for the treatment of relapsing forms of multiple sclerosis, to include clinically isolated syndrome, ...
TYSABRI® (natalizumab)
https://www.tysabri.com
TYSABRI is a prescription medicine used to treat relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting ...